ロード中...
Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
Cetuximab and panitumumab, as the highly effective antibodies targeting epidermal growth factor receptor (EGFR), have clinical activity in the patients with metastatic colorectal cancer (mCRC). These agents have good curative efficacy, but drug resistance also exists at the same time. The effects of...
保存先:
| 出版年: | Gastroenterol Rep (Oxf) |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7333932/ https://ncbi.nlm.nih.gov/pubmed/32665850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goaa026 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|